Prospective Comparison of Valacyclovir and Oral Ganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients

Publisher： Karger

E-ISSN： 1423-0143|28|4|218-225

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.28, Iss.4, 2005-12, pp. : 218-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago

By  

Case Reports in Nephrology and Dialysis, Vol. 5, Iss. 1, 2015-04 ,pp. : 96-105

Karger

Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 4, 2014-09 ,pp. : 308-314

Karger

Access to resources Recommend Favorite

Clinical Course of Cytomegalovirus (CMV) Viremia with and without Ganciclovir Treatment in CMV-Seropositive Kidney Transplant Recipients

By  

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 373-378

Karger

Access to resources Recommend Favorite

Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-05 ,pp. : 407-416

Karger

Access to resources Recommend Favorite

Effects of Mediterranean Diet on Lipid Levels and Cardiovascular Risk in Renal Transplant Recipients

By  

Nephron, Vol. 82, Iss. 3, 1999-06 ,pp. : 199-204

Karger

Access to resources Recommend Favorite